Evidence map›Paper›PMID 35079318›Full record

ArticleThe World Allergy Organization journal2022

Prevalence of asthma symptoms and associated risk factors among adults in Saudi Arabia: A national survey from Global Asthma Network Phase Ⅰ.

Shaker A Alomary, Ahmed J Al Madani, Wael A Althagafi, Izzeldin F Adam, Omneya E Elsherif, Aljoharah A Al-Abdullaah, Hamdan Al-Jahdali, Hani A Jokhdar, Saeed H Alqahtani, Mahmoud A Nahhas and 1 more

Open access · goldAbstract read
In one paragraph

Article in The World Allergy Organization journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.8field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Gut microbiome signature and nasal lavage inflammatory markers in young people with asthma.The journal of allergy and clinical immunology. Global · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Shaker A AlomaryGeneral Directorate of Health Programs and Chronic Diseases, Ministry of Health, Riyadh, Saudi Arabia.
Ahmed J Al MadaniGeneral Directorate of Health Programs and Chronic Diseases, Ministry of Health, Riyadh, Saudi Arabia.
Wael A AlthagafiGeneral Directorate of Health Programs and Chronic Diseases, Ministry of Health, Riyadh, Saudi Arabia.
Izzeldin F AdamGeneral Directorate of Health Programs and Chronic Diseases, Ministry of Health, Riyadh, Saudi Arabia.
Omneya E ElsherifGeneral Directorate of Health Programs and Chronic Diseases, Ministry of Health, Riyadh, Saudi Arabia.
Aljoharah A Al-AbdullaahGeneral Directorate of Health Programs and Chronic Diseases, Ministry of Health, Riyadh, Saudi Arabia.
Hamdan Al-JahdaliDepartment of Medicine-Pulmonary Division, King Saud Bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Hani A JokhdarDeputyship of Public Health, Ministry of Health, Riyadh, Saudi Arabia.
Saeed H AlqahtaniGeneral Directorate of Health Programs and Chronic Diseases, Ministry of Health, Riyadh, Saudi Arabia.
Mahmoud A NahhasGeneral Administration of School Health, Ministry of Health, Riyadh, Saudi Arabia. Currently, Public Health Consultant, Riyadh, Saudi Arabia.
Rasha A AlfawazAffairs for Health Improvement and Promotion, Saudi Public Health Authority, Riyadh, Saudi Arabia.
Ministry of Health · SAKing Saud bin Abdulaziz University for Health Sciences · SAUniversity of Khartoum · SD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeEstimating the prevalence and severity of asthma symptoms with standardized methods of population-based surveys is a critical step in reducing asthma burden. However, no sufficient surveys have been conducted in most countries of the Middle East especially at the national level. In this survey, we applied sound measures to estimate the prevalence and severity of asthma symptoms and related risk factors in adults in Saudi Arabia. PATIENTS AND

methodsIn this national cross-sectional study, the prevalence and severity of asthma symptoms were estimated throughout the country. Overall, 7955 adult individuals were selected from 20 regions across Saudi Arabia through their children at schools using a multistage, stratified cluster-sampling technique. A validated questionnaire, including the core and environmental questions of the Global Asthma Network questionnaires, was applied from March 4 to April 25, 2019. In addition, multivariate logistic regression analysis was performed to investigate the independent relationships between current wheeze and related risk factors.

resultsThe overall prevalence of current wheeze (wheeze during the past 12 months) was 14.2%. Among persons with current wheeze, 38.1% were affected by severe asthma symptoms. Although a high percentage of those who had experienced asthma-ever reported that their asthma was diagnosed by doctors (83.3%), only 38.4% had a written plan for controlling their asthma. Women were more likely to develop current wheeze (adjusted odds ratio (aOR) 1.4; 95% CI: 1.1-1.7), while other statistically significant factors associated with current wheeze were jobs (aOR 11.8; 95% CI: 7.3-18.9), current exposure to moisture or damp spots (aOR 2.2; 95% CI: 1.5-3.4), heating the house when it is cold (aOR 1.7; 95% CI: 1.3-2.1), and ever using tobacco daily (aOR 2.7; 95% CI: 2.0-3.5).

conclusionsThese findings provide enough evidence for health authorities in Saudi Arabia about the prevalence and severity of asthma symptoms, asthma control, and associated risk factors to scale up monitoring projects, control plans, and high-impact interventions.

Indexed as

Allergic conditionsAsthma prevalenceGlobal Asthma NetworkMiddle EastRisk factors

Identifiers

PMID35079318
PMCPMC8760440
OpenAlexW4205648040

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.